A New Option for Early Breast Cancer Treatment
By Radiant Health EditorsPublished: October 17, 2021
Health News Briefs
Breast cancer is a treatable form of cancer, but few advancements have been made in the field in the last two decades. The drug abemaciclib, or Verzenio, may be the best option for the vast majority of people living with the disease. Verzenio is already being used to treat metastatic breast cancer, but the FDA recently approved it for use in individuals with early breast cancer. Many doctors and scientists are applauding the decision and are hopeful that breast cancer will become less deadly as a result.
Radiant is published in Print & Digital. Download a free digital edition at radianthealthmag.com/free.
- Coconut Cauliflower Rice With Jerk Chicken - November 29, 2024
- Protein Cottage Cheese Pancakes - November 27, 2024
- How To Reduce Screen Time On Phone: 5 Helpful Strategies To Help You Stay Connected With The Real World - October 30, 2024
- 11 Wellness Gift Ideas: Perfect Presents for Her that Nurture Body, Mind, and Soul - October 13, 2024
- 11 Best Indoor Air Purifying Plants: Nature’s Air Filters for Your Home - September 27, 2024
- 11 Best Health and Wellness Books to Read in 2025 - July 4, 2024
- Some Americans Will Have Medical Debt Wiped From Credit - July 9, 2022
- Natural Gas Used to Heat Homes Contains Some Harmful Chemicals - July 9, 2022
- Uterine Cancer Claims Many Black Lives - July 9, 2022
- Babies and Toddlers Get COVID-19 Shots - June 27, 2022